Niagen Bioscience, Inc.
US ˙ NasdaqCM ˙ US1710774076

SecurityNAGE / Niagen Bioscience, Inc.
InstitutionCitadel Advisors Llc
ManagerKen Griffin
Latest Disclosed Ownership530,477 shares
Latest Disclosed Value $ 2,339,404
Citadel Advisors Llc ownership in NAGE / Niagen Bioscience, Inc.

On May 15, 2026 - Citadel Advisors Llc filed a 13F-HR form disclosing ownership of 530,477 shares of Niagen Bioscience, Inc. (US:NAGE) valued at $2,339,404 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 17, 2026 disclosing 391,540 shares of Niagen Bioscience, Inc.. This represents a change in shares of 35.48% during the quarter. The current value of the position is $1,830,146 USD.

Citadel Advisors Llc has a history of taking positions in derivatives of the underlying security (NAGE) in the form of stock options. The firm currently holds call options representing 18,300 of underlying shares valued at $80,703 USD and put options representing 129,500 of underlying shares valued at $571,095 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

NAGE / Niagen Bioscience, Inc. Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F NIAGEN BIOSCIENCE COM NEW 171077407 530,477 138,937 35.48 2,339 -6.06 0.0003
2026-02-17 2025-12-31 13F NIAGEN BIOSCIENCE COM NEW 171077407 391,540 192,237 96.45 2,490 33.94 0.0004
2025-11-14 2025-09-30 13F NIAGEN BIOSCIENCE COM NEW 171077407 199,303 199,303 1,859 0.0003
2025-08-14 2025-06-30 13F NIAGEN BIOSCIENCE COM NEW 171077407 0 -106,899 -100.00 0 -100.00
2025-05-15 2025-03-31 13F NIAGEN BIOSCIENCE COM NEW 171077407 106,899 80,284 301.65 738 422.70 0.0001
2025-02-14 2024-12-31 13F CHROMADEX COM NEW 171077407 26,615 26,313 8,712.91 141 14,000.00 0.0000
2024-11-14 2024-09-30 13F CHROMADEX COM NEW 171077407 302 -9,650 -96.97 1 -96.30 0.0000
2024-08-14 2024-06-30 13F CHROMADEX COM NEW 171077407 9,952 -31,081 -75.75 27 -80.99 0.0000
2024-05-15 2024-03-31 13F CHROMADEX COM NEW 171077407 41,033 -138,662 -77.17 143 -44.53 0.0000
2024-02-14 2023-12-31 13F CHROMADEX COM NEW 171077407 179,695 6,925 4.01 257 1.59 0.0001
2023-11-14 2023-09-30 13F CHROMADEX COM NEW 171077407 172,770 -14,443 -7.71 252 -13.99 0.0001
2023-08-14 2023-06-30 13F CHROMADEX COM NEW 171077407 187,213 -22,779 -10.85 294 -8.72 0.0001
2023-05-15 2023-03-31 13F CHROMADEX COM NEW 171077407 209,992 59,701 39.72 321 27.38 0.0001
2023-02-14 2022-12-31 13F CHROMADEX COM NEW 171077407 150,291 93,726 165.70 252 260.00 0.0001
2022-11-14 2022-09-30 13F CHROMADEX COM NEW 171077407 56,565 -316,992 -84.86 70 -88.76 0.0000
2022-08-15 2022-06-30 13F CHROMADEX COM NEW 171077407 373,557 264,478 242.46 623 132.46 0.0002
2022-05-16 2022-03-31 13F CHROMADEX COM NEW 171077407 109,079 -38,144 -25.91 268 -51.36 0.0001
2022-02-14 2021-12-31 13F CHROMADEX COM NEW 171077407 147,223 112,257 321.05 551 151.60 0.0001
2021-11-15 2021-09-30 13F CHROMADEX Cmn 171077407 34,966 5,740 19.64 219 -23.96 0.0000
2021-08-16 2021-06-30 13F CHROMADEX COM NEW 171077407 29,226 -44,081 -60.13 288 -57.96 0.0001
2021-05-21 2021-03-31 13F/A-1 CHROMADEX COM NEW 171077407 73,307 73,307 150.83 685 137.85 0.0002
2021-05-17 2021-03-31 13F CHROMADEX COM NEW 171077407 73,307 73,307 685 0.0002
2020-11-16 2020-09-30 13F CHROMADEX Cmn 171077407 0 -29,704 -100.00 0 -100.00
2020-08-14 2020-06-30 13F CHROMADEX Cmn 171077407 29,704 -43,751 -59.56 137 -42.68 0.0000
2020-05-15 2020-03-31 13F CHROMADEX Cmn 171077407 73,455 73,455 147.29 239 74.45 0.0001
2019-05-15 2019-03-31 13F CHROMADEX Cmn 171077407 0 -21,050 -100.00 0 -100.00
2019-02-14 2018-12-31 13F CHROMADEX Cmn 171077407 21,050 -23,286 -52.52 72 -62.11 0.0000
2018-11-13 2018-09-30 13F CHROMADEX Cmn 171077407 44,336 27,315 160.48 190 201.59 0.0001
2018-08-14 2018-06-30 13F/A-1 CHROMADEX Cmn 171077407 17,021 -42,319 -71.32 63 -74.70 0.0000
2018-08-10 2018-06-30 13F CHROMADEX Cmn 171077407 17,021 -42,319 63
2018-05-14 2018-03-31 13F/A-1 CHROMADEX Cmn 171077407 59,340 59,340 249 0.0001
2018-05-11 2018-03-31 13F CHROMADEX Cmn 171077407 59,340 249 0.0001
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-05-15 2026-03-31 13F NIAGEN BIOSCIENCE COM NEW Call 18,300 -8.50 81 -37.01 n/a n/a n/a
2026-02-17 2025-12-31 13F NIAGEN BIOSCIENCE COM NEW Call 20,000 -63.30 127 -75.00 n/a n/a n/a
2025-11-14 2025-09-30 13F NIAGEN BIOSCIENCE COM NEW Call 54,500 130.93 508 49.41 n/a n/a n/a
2025-08-14 2025-06-30 13F NIAGEN BIOSCIENCE COM NEW Call 23,600 -26.02 340 54.55 n/a n/a n/a
2025-05-15 2025-03-31 13F NIAGEN BIOSCIENCE COM NEW Call 31,900 -21.04 220 2.80 n/a n/a n/a
2025-02-14 2024-12-31 13F CHROMADEX COM NEW Call 40,400 51.88 214 120.62 n/a n/a n/a
2024-11-14 2024-09-30 13F CHROMADEX COM NEW Call 26,600 48.60 97 102.08 n/a n/a n/a
2024-08-14 2024-06-30 13F CHROMADEX COM NEW Call 17,900 -30.62 49 -46.07 n/a n/a n/a
2024-05-15 2024-03-31 13F CHROMADEX COM NEW Call 25,800 821.43 90 2,125.00 n/a n/a n/a
2024-02-14 2023-12-31 13F CHROMADEX COM NEW Call 2,800 64.71 4 100.00 n/a n/a n/a
2023-11-14 2023-09-30 13F CHROMADEX COM NEW Call 1,700 -75.71 2 -80.00 n/a n/a n/a
2023-08-14 2023-06-30 13F CHROMADEX COM NEW Call 7,000 -85.20 11 -86.11 n/a n/a n/a
2023-05-15 2023-03-31 13F CHROMADEX COM NEW Call 47,300 -47.62 72 -52.32 n/a n/a n/a
2023-02-14 2022-12-31 13F CHROMADEX COM NEW Call 90,300 135.16 152 221.28 n/a n/a n/a
2022-11-14 2022-09-30 13F CHROMADEX COM NEW Call 38,400 8.17 47 -20.34 n/a n/a n/a
2022-08-15 2022-06-30 13F CHROMADEX COM NEW Call 35,500 -72.61 59 -81.50 n/a n/a n/a
2022-05-16 2022-03-31 13F CHROMADEX COM NEW Call 129,600 502.79 319 298.75 n/a n/a n/a
2022-02-14 2021-12-31 13F CHROMADEX COM NEW Call 21,500 -38.75 80 -63.64 n/a n/a n/a
2021-11-15 2021-09-30 13F CHROMADEX Cmn Call 35,100 -41.98 220 -63.15 n/a n/a n/a
2021-08-16 2021-06-30 13F CHROMADEX COM NEW Call 60,500 -22.83 597 -18.44 n/a n/a n/a
2021-05-21 2021-03-31 13F/A CHROMADEX COM NEW Call 78,400 732 n/a n/a n/a
2021-05-17 2021-03-31 13F CHROMADEX COM NEW Call 78,400 732 n/a n/a n/a
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-05-15 2026-03-31 13F NIAGEN BIOSCIENCE COM NEW Put 129,500 -4.36 571 -33.68 n/a n/a n/a
2026-02-17 2025-12-31 13F NIAGEN BIOSCIENCE COM NEW Put 135,400 338.19 861 198.96 n/a n/a n/a
2025-11-14 2025-09-30 13F NIAGEN BIOSCIENCE COM NEW Put 30,900 -34.26 288 -57.46 n/a n/a n/a
2025-08-14 2025-06-30 13F NIAGEN BIOSCIENCE COM NEW Put 47,000 233.33 677 597.94 n/a n/a n/a
2025-05-15 2025-03-31 13F NIAGEN BIOSCIENCE COM NEW Put 14,100 143.10 97 223.33 n/a n/a n/a
2025-02-14 2024-12-31 13F CHROMADEX COM NEW Put 5,800 -29.27 31 3.45 n/a n/a n/a
2024-11-14 2024-09-30 13F CHROMADEX COM NEW Put 8,200 34.43 30 81.25 n/a n/a n/a
2024-08-14 2024-06-30 13F CHROMADEX COM NEW Put 6,100 -3.17 17 -23.81 n/a n/a n/a
2024-05-15 2024-03-31 13F CHROMADEX COM NEW Put 6,300 22 n/a n/a n/a
2023-11-14 2023-09-30 13F CHROMADEX COM NEW Put 0 -100.00 0 -100.00 n/a n/a n/a
2023-08-14 2023-06-30 13F CHROMADEX COM NEW Put 2,100 -30.00 3 -25.00 n/a n/a n/a
2023-05-15 2023-03-31 13F CHROMADEX COM NEW Put 3,000 7.14 5 0.00 n/a n/a n/a
2023-02-14 2022-12-31 13F CHROMADEX COM NEW Put 2,800 5 n/a n/a n/a
2022-11-14 2022-09-30 13F CHROMADEX COM NEW Put 0 -100.00 0 -100.00 n/a n/a n/a
2022-08-15 2022-06-30 13F CHROMADEX COM NEW Put 22,100 -56.41 37 -70.40 n/a n/a n/a
2022-05-16 2022-03-31 13F CHROMADEX COM NEW Put 50,700 125 n/a n/a n/a
2022-02-14 2021-12-31 13F CHROMADEX Cmn Put 0 -100.00 0 -100.00 n/a n/a n/a
2021-11-15 2021-09-30 13F CHROMADEX Cmn Put 67,400 -48.43 423 -67.18 n/a n/a n/a
2021-08-16 2021-06-30 13F CHROMADEX COM NEW Put 130,700 -3.61 1,289 1.74 n/a n/a n/a
2021-05-21 2021-03-31 13F/A CHROMADEX COM NEW Put 135,600 1,267 n/a n/a n/a
2021-05-17 2021-03-31 13F CHROMADEX COM NEW Put 135,600 1,267 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.